Overview
Masakazu Nakano practices in Kyoto, Japan. Mr. Nakano is rated as a Distinguished expert by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Pigment-Dispersion Syndrome, and Glaucoma.
His clinical research consists of co-authoring 48 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles in the study of Fuchs Dystrophy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Fuchs DystrophyMr. Nakano isDistinguished. Learn about Fuchs Dystrophy.
- GlaucomaMr. Nakano isDistinguished. Learn about Glaucoma.
- Macular Corneal Dystrophy Type 1Mr. Nakano isDistinguished. Learn about Macular Corneal Dystrophy Type 1.
- Ocular Hypertension (OHT)Mr. Nakano isDistinguished. Learn about Ocular Hypertension (OHT).
- Pigment-Dispersion SyndromeMr. Nakano isDistinguished. Learn about Pigment-Dispersion Syndrome.
- Experienced
- B-Cell LymphomaMr. Nakano isExperienced. Learn about B-Cell Lymphoma.
- CACH SyndromeMr. Nakano isExperienced. Learn about CACH Syndrome.
- Follicular LymphomaMr. Nakano isExperienced. Learn about Follicular Lymphoma.
- Mantle Cell Lymphoma (MCL)Mr. Nakano isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaMr. Nakano isExperienced. Learn about Non-Hodgkin Lymphoma.